DIRECTOR OF SEC REPORTING | Halia Therapeutics, Inc. · Teeming.ai
Halia Therapeutics, Inc.
Halia Therapeutics is a biopharmaceutical company focused on revolutionizing chronic inflammation therapy by studying individuals with genetic resilience. Their approach decodes natural disease resistance to identify protective biological mechanisms, leading to the development of novel drug targets and safer, more effective therapies. The company utilizes its proprietary GENMOR platform, enhanced by AI (GENMOR-AI), to analyze genetic and health data, accelerating the discovery of human-validated targets. Halia has advanced drug candidates for Alzheimer's disease, myelodysplastic syndrome (MDS), and obesity, which are currently in clinical trials. They aim to create a future where longevity and vitality are improved by harnessing genetic resilience.
Halia Therapeutics is a biopharmaceutical company focused on revolutionizing chronic inflammation therapy by studying individuals with genetic resilience. Their approach decodes natural disease resistance to identify protective biological mechanisms, leading to the development of novel drug targets and safer, more effective therapies. The company utilizes its proprietary GENMOR platform, enhanced by AI (GENMOR-AI), to analyze genetic and health data, accelerating the discovery of human-validated targets. Halia has advanced drug candidates for Alzheimer's disease, myelodysplastic syndrome (MDS), and obesity, which are currently in clinical trials. They aim to create a future where longevity and vitality are improved by harnessing genetic resilience.
Teeming tracks opportunities at over 24,000 AI startups, then works with you to find (and land) the one you'll love.
Product Designer
Full-timeRotterdam, NL
Full-time • Rotterdam, NL
Technical Writer
Part-timeRotterdam, NL
Part-time • Rotterdam, NL
Machine Learning Engineer
InternshipNiš, RS
Internship • Niš, RS
Product Designer
Full-timeNiš, RS
Full-time • Niš, RS
Mobile Developer
Full-timeLondon, GB
Full-time • London, GB
Software Engineer
InternshipNiš, RS
Internship • Niš, RS
Job Overview
The Director of SEC Reporting will play a critical leadership role in preparing Halia for life as a public company. Reporting to the Chief Financial Officer, this individual will build and lead the company’s SEC reporting and internal control infrastructure in advance of an anticipated IPO and beyond.
This role will own the design and execution of external financial reporting processes, help establish SOX-ready internal controls, and partner cross-functionally to ensure Halia is positioned to meet public company standards. The ideal candidate is both highly technical and hands-on, with experience guiding organizations through IPO readiness or first-time public reporting.
Responsibilities
Qualifications
Bachelor’s degree in Accounting, Finance, or related field;
CPA required
.
10+ years of progressive accounting experience, including leadership in SEC reporting and technical accounting.
Public accounting background strongly preferred; biotech or life sciences experience a plus.
Prior experience supporting IPO readiness and/or operating as a newly public company is highly desirable.
Strong technical expertise in U.S. GAAP, SEC reporting requirements, and internal controls.
Location
Flexible hybrid or remote arrangements may be considered based on candidate experience and business needs, but in-office work will be preferred for IPO process.
Compensation & Benefits
Halia offers a competitive compensation package, including base salary, annual bonus opportunity, meaningful equity participation, and a comprehensive benefits program.
Lead the build-out of Halia’s SEC reporting function in preparation for an IPO, including drafting registration statement financials and related disclosures.
Prepare and review external financial reporting materials, including IPO filings (e.g., S-1) and subsequent periodic SEC reports (10-Q, 10-K, 8-K) post-IPO.
Own financial statement preparation, footnotes, and MD&A in accordance with U.S. GAAP and SEC requirements.
Establish scalable processes and timelines to support accurate, timely, and high-quality external reporting.
Partner closely with Legal, Investor Relations, and Executive Leadership to ensure consistent and clear financial messaging across filings, investor materials, and public disclosures.
Monitor emerging accounting standards and SEC rules; assess impact and lead implementation.
Design and implement a SOX-ready internal control framework, including risk assessment, control design, documentation, and initial testing.
Collaborate with the Corporate Controller to formalize accounting policies and procedures aligned with public company best practices.
Serve as a primary liaison with external auditors, IPO advisors, and other external consultants.
Support the CFO and senior leadership on technical accounting matters, equity and financing transactions, and other strategic initiatives.
Assist in building and mentoring the SEC reporting and controls capability as the company scales.
Proven ability to build processes from the ground up in a fast-paced, evolving environment.
Excellent written and verbal communication skills with strong attention to detail.
Effective cross-functional collaborator with a pragmatic, solutions-oriented mindset.
